Neuromodulation orchestrates the delicate dance of neural activity within the intricate tapestry of the nervous system. Unlike the rapid synaptic transmission mediated by neurotransmitters, neuromodulators operate on longer timescales, exerting influence over multiple neurons simultaneously. They regulate neuronal activity across various levels of the nervous system, from individual synapses to entire brain regions. These modulators encompass both endogenous substances, such as dopamine and serotonin, which naturally regulate neural function, and exogenous agents, like electrical stimulation or pharmacological compounds, introduced to alter neural activity. Neuromodulation's effects span from modifying neuronal excitability to shaping synaptic plasticity, the foundation of learning and memory. In the realm of basic neuroscience research, neuromodulation techniques unravel the complexities of neuronal circuits, shedding light on how these circuits sculpt behavior and cognition. Clinically, neuromodulation therapies offer promising avenues for treating neurological and psychiatric disorders, from chronic pain to depression, leveraging approaches like deep brain stimulation and transcranial magnetic stimulation to restore neural balance.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States